Literature DB >> 4054721

Successful treatment of pseudomyxoma peritonei of ovarian origin with cis-platinum, doxorubicin, and cyclophosphamide.

C M Jones, H D Homesley.   

Abstract

Pseudomyxoma peritonei is a rare disease characteristically secondary to mucin-producing adenocarcinomas of the ovary and appendix. Though, as a rule, not invasive or metastatic, death occurs secondary to gastrointestinal dysfunction. This is the first case of pseudomyxoma peritonei secondary to an ovarian primary possibly cured by systemic cis-platinum, doxorubicin, and cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054721     DOI: 10.1016/0090-8258(85)90035-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach.

Authors:  D B Gough; J H Donohue; A J Schutt; N Gonchoroff; J R Goellner; T O Wilson; J M Naessens; P C O'Brien; J A van Heerden
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

2.  Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).

Authors:  Chin-Fan Chen; Che-Jen Huang; Wan-Yi Kang; Jan-Sing Hsieh
Journal:  World J Surg Oncol       Date:  2008-11-11       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.